KD · Kyndryl Holdings, Inc.

The thesis

Kyndryl's profit and signings improved in the September quarter, but cash did not, and the shares' jump after the report has moved ahead of the numbers. The evidence still points to the shares more likely lagging the S&P 500 than leading it over the next three months. The fiscal third-quarter report, around early February 2027, settles whether the $400–500 million fiscal 2027 free-cash-flow target survives.

The 4 November 2026 report answered half of the question the previous note posed. Adjusted pretax income rose to $150 million from $123 million a year earlier, and signings rose to $4.1 billion from $2.8 billion (company release). Free cash flow was a $34 million outflow, taking the first half to a $434 million outflow, while management reaffirmed the full-year target.

The market paid for the good half. Shares traded at $16.34 early on 4 November 2026, up more than 26% from the prior close of $12.94 (IBTimes), and closed at $16.29 on 6 November 2026. That sits just above the $16 average 12-month analyst target reported by fiscal.ai on 5 November 2026.

The narrative is accelerating: the 4 November 2026 report brought the first new financial results since 5 August 2026, and Scotiabank and Susquehanna raised targets the next day.

Bullish and bearish views on Kyndryl Holdings, Inc.

The bull case on Kyndryl Holdings, Inc. (KD), in brief: Signings rebuilt the order book. The bear case: The cash target needs a steep ramp.

Bull case

• Signings rebuilt the order book. September-quarter signings of $4.1 billion compare with $2.8 billion a year earlier, and included 11 contracts above $50 million. Trailing-twelve-month signings reached $15.5 billion on 30 September 2026, up from $14.2 billion three months earlier (company releases, 5 August 2026 and 4 November 2026).
• Profit turned positive with margins higher. Adjusted pretax income swung to $150 million from a $37 million first-quarter loss. Adjusted EBITDA (earnings before interest, tax, depreciation and amortization) margin rose to 19.1% from 17.2% a year earlier (company release, 4 November 2026).
• Restructuring charges are nearly finished. Workforce charges reached $190 million in the first half against about $200 million expected for fiscal 2027. The company expects savings to begin in the second half and targets a $400–500 million annual cost run rate reduction in fiscal 2028 (company release, 4 November 2026).
• Expectations started low. A tally by AlphaStreet cited by IBTimes on 5 November 2026 showed no positive analyst ratings, seven neutral and four negative. Adjusted earnings per share of $0.42 beat Benzinga's $0.38 estimate, though Investing.com's estimate was $0.41.

Bear case

• The cash target needs a steep ramp. Finsee calculates that the $450 million midpoint needs about $884 million of free cash flow in the second half, up 46.1% from $605 million a year earlier. Its review of the 4 November 2026 report also shows net capital spending up 64.8% to $206 million in the quarter.
• A similar ramp failed last year. Morgan Stanley said in November 2025 that Kyndryl needed a back-half ramp to reach its goals. On 9 February 2026 the company cut fiscal 2026 free-cash-flow guidance to $325–375 million from about $550 million.
• Growth lines slowed in the quarter. Hyperscaler-related revenue grew 27.2% to above $550 million, against 34% in the June quarter. Kyndryl Consult revenue grew 4.2%, against 10% (company releases, 5 August 2026 and 4 November 2026).
• Liquidity tightened and funding costs rose. Cash fell to $1.66 billion on 30 September 2026 from $2.62 billion on 31 March 2026, against $4.06 billion of debt. On 28 September 2026 Kyndryl issued 7.80% and 7.875% notes, in part to repay 2.05% notes (company release, 4 November 2026).
• The governance overhang remains open. The 4 November 2026 release still lists remediating material weaknesses as a risk, and Finsee found no update there on the Securities and Exchange Commission (SEC) review. The weaknesses disclosed earlier in 2026 involved deferred vendor payments (Yahoo Finance), which bears directly on how cash flow is read. This note could not confirm what the September-quarter Form 10-Q says on the inquiry.

Price setup

The last close was $16.29 on 6 November 2026, up 21.9% over three months in adjusted daily closes. That is 40.8% below the 52-week high of $27.50. The close of $12.94 on 3 November 2026 (IBTimes) is the clearest reference level, because the report produced almost all of the gain since.

The crowding evidence is modest. The 14-day relative strength index, a momentum gauge often read as stretched above 70, was 67.0 on 6 November 2026. Targets bracket the price: Susquehanna's is $16, raised from $13 with a neutral rating, and Scotiabank's is $19 with a sector-perform rating (Benzinga, 5 November 2026). No earnings date falls in the next several weeks. Share repurchases slowed to $97 million in the first half from $151 million a year earlier (company release, 4 November 2026).

Catalysts, next 30 days

• Through 7 December 2026: No company-scheduled financial event was found. The AWS agentic modernization partnership was announced on 5 November 2026, ahead of this window (Benzinga).
• ~3 February 2027, est.: Fiscal third-quarter 2027 report. Last year's equivalent report came with the guidance cut on 9 February 2026. December-quarter free cash flow is the first direct test of the second-half target.

What would change the view

The recovery case breaks if Kyndryl cuts the $400–500 million free-cash-flow target, discloses a restatement, a delayed periodic report or added material weaknesses, or receives a Wells notice from the SEC. On price, a close below $12.94 would erase the gain from the report. The shares closed under the $13.00 invalidation level in the previous note on 3 November 2026, before the results reversed the move.

The view that the shares lag would prove wrong if the December quarter shows a large free-cash-flow inflow with the target reaffirmed, and without added reliance on deferred vendor payments. Upgrades from neutral or negative analysts following that report would support the same conclusion. Outperformance of the S&P 500 through the February report would also show the call was wrong.

What it trades with

Kyndryl's move came from its own report, on a day when the Dow rallied 2.9% after the midterm elections and hyperscalers rose (Benzinga, 4 November 2026). Part of the report-day gain may therefore reflect the market. A reversal in that rally would test the shares without any change in the business.

FrontierPicks' tracking of the AI enterprise software group, which includes ACN, EPAM, GLOB and GDYN, moved to accelerating on 6 November 2026 from maturing on 1 November 2026. That helps sentiment but does not decide this case, because the cash and governance questions are specific to Kyndryl. Peer strength would matter less if Kyndryl's December-quarter cash flow disappoints.